Advertisement
News
Subscribe to MDT Magazine News

Bacterin International Holdings, Inc. Schedules Conference Call to Present Fourth Quarter and Full Year 2010 Financial Results

March 17, 2011 8:35 am | by Bio-Medicine.Org | Comments

BELGRADE, Mont., March 17, 2011 /- Bacterin International Holdings, Inc. (NYSE Amex: BONE ) ("Bacterin"), announced today that it has scheduled a conference call for Tuesday, March 29, 2011 at 10:00 a.m. (ET) to discuss the Company's financial results for its fourth quarter and full year...

TOPICS:

Ten States Bear Brunt of Diabetes Burden

March 17, 2011 7:31 am | by Bio-Medicine.Org | Comments

WASHINGTON, March 17, 2011 /- A new study conducted by the Institute for Alternative Futures (IAF) identified California, Texas, Florida, New York, Ohio, Illinois, Georgia, Pennsylvania, North Carolina and Michigan as "diabetes hot spots," where the burden of diabetes will be greatest in...

TOPICS:

Exergen Granted New Patent for Temporal Artery Thermometers

March 17, 2011 7:31 am | by Bio-Medicine.Org | Comments

WATERTOWN, Mass., March 17, 2011 /- A recently issued patent extends protection of the technology incorporated in Exergen's award winning and best selling medical thermometer brand, the TemporalScanner™ Temporal Artery Thermometers.  Exergen Corporation has recently been...

TOPICS:
Advertisement

Most comprehensive collection of fungal cell biology movies ever published

March 17, 2011 6:34 am | by EurekAlert | Comments

(Elsevier) A recent special edition of the journal Fungal Biology Reviews, published by Elsevier, on behalf of the British Mycological Society, features a total of 76 videos which together comprise the most comprehensive collection of fungal cell biology movies ever published. The...

TOPICS:

An Improved Dry Eye Medication - ICAP Ocean Tomo Announces Auction of a New Collyrium From Aqueous Pharma Limited

March 17, 2011 6:32 am | by Bio-Medicine.Org | Comments

CHICAGO, March 17, 2011 /- Developed by Aqueous Pharma Limited and represented by ICAP Ocean Tomo , this patent pending technology discloses an improved formulation for treating eye disease, specifically chronic dry eye. The assets in this portfolio will be auctioned at ICAP Ocean Tomo's...

TOPICS:

Startup EndoLumina wins AUTM inaugural pitch contest

March 17, 2011 5:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Needham-based medical device startup EndoLumina Inc., which is developing devices to monitor gastrointestinal bleeding and related diseases, won the first-ever $10,000 AUTM (Association of University Transfer Managers) Venture Pitch Competition.

SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China

March 17, 2011 5:32 am | by Bio-Medicine.Org | Comments

WASHINGTON, LONDON and HONG KONG, March 17, 2011 /- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology Co., Ltd. ("KSB"), a...

TOPICS:

Fujifilm's Exclusive Software Advances Cardiovascular Reporting Capabilities

March 17, 2011 5:32 am | by Bio-Medicine.Org | Comments

STAMFORD, Conn., March 17, 2011 /- ACC Booth # 2001 -- Further enhancing its cardiovascular reporting capabilities, FUJIFILM Medical Systems U.S.A., Inc. is pleased to announce the availability of its Intelligent Structured Reporting (ISR) technology. An advanced software decision support...

TOPICS:
Advertisement

Amarin Reports Year-End and Q4 2010 Results

March 17, 2011 5:31 am | by Bio-Medicine.Org | Comments

DUBLIN and MYSTIC, Conn., March 16, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ), a clinical-stage biopharmaceutical company focused on cardiovascular disease, today reported financial results for the fiscal year and fourth quarter ended December 31, 2010. The Company also provided an...

TOPICS:

ImmuCell Announces Sales and Marketing Collaboration With AgriLabs

March 17, 2011 4:45 am | by The Associated Press | Comments

ImmuCell Corporation (NASDAQ: ICCC) today announced that it has entered into a sales and marketing collaboration with Agri Laboratories Ltd. of St. Joseph, Missouri.The AgriLabs sales and marketing teams will work with ImmuCell to expand market demand for First Defense@. All sales...

STAAR Surgical Launches Second Phase of Visian ICL Direct-to-Consumer Advertising Campaign

March 17, 2011 4:31 am | by Bio-Medicine.Org | Comments

MONROVIA, Calif., March 17, 2011 /- STAAR Surgical Company (Nasdaq: STAA ), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced the launch of phase two of its direct-to-consumer advertising campaign. Phase two has three planned...

TOPICS:

PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials

March 17, 2011 2:35 am | by Bio-Medicine.Org | Comments

BOSTON, March 17, 2011 /- Experts from PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, will address best-practice strategic partnership models to increase operating efficiency and improve development effectiveness during the 20th...

TOPICS:

Vincotech?s highly efficient power module solution with MNPC topology

March 17, 2011 1:37 am | by I-Micronews | Comments

3xflowMNPC 4w ? a breakthrough for low-inductive power modules with power rating up to 250kW.

Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results

March 17, 2011 12:36 am | by Bio-Medicine.Org | Comments

BLUE BELL, Pa., March 17, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO ) today reported financial results for the fourth quarter and year ended December 31, 2010. Total revenue was $2.4 million and $6.1 million for the quarter and year ended December 31, 2010, compared to $2.6...

TOPICS:

VTI Technologies announces record sales in 2010

March 16, 2011 10:36 pm | by I-Micronews | Comments

VTI Technologies, a leading supplier of 3D MEMS sensors announces excellent results for 2010. The Group?s net sales increased by 42 percent and totalled EUR 75.8 million (EUR 53.6 million in 2009).

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading